Accelerated <i>BRAF</i> mutation analysis using a fully automated PCR platform improves the management of patients with metastatic melanoma.

But, the number of subjects was sufficient to demonstrate statistically significant difference due to the large expected difference of delay between the two groups: for the delay between reception of the FFPE samples and receipt of the results by the oncologist, the difference between the two groups was highly significant ( p < 0.001) with an a posteriori power of 98%.

also in 132,142 other papers